1️⃣ $LRMR (Larimar Therapeutics) | 🧬 Biotechnology

Current Status:

• Price: $3.68 (+30.97%)
• Float: 46M
• Premarket Volume: 27.50M (3100% RVOL)
• Key Times: Premarket high 4.04 at 9:18 AM ET, Support test 2.88 at open PM

Trading Levels:

• Premarket Range: $2.88–$4.04
• Key Support: $3.25 (overnight), $3.50 (late PM consolidation)
• Entry Zones: → $3.55 / $3.68

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.90 | T2 $4.04 | T3 $4.25 | T4 $4.50 | T5 $5.00
• Stop Loss: $3.35 (dynamic, max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision Breakout #3 (+37%), Movers Gainers #4
• Volume: 27.50M shares, $103.38M dollar volume (3100% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Breakout with higher lows (5m)
• Catalyst: FDA Breakthrough Therapy Designation for Nomlabofusp in FA; reiterates planned BLA submission June 2026 — TrendVision NEWS/SEC FORM 8-K

---

2️⃣ $VIR (Vir Biotechnology) | 🧬 Biotechnology

Current Status:

• Price: $9.97 (+34.17%)
• Float: 85.53M
• Premarket Volume: 7.77M (2400% RVOL)
• Key Times: Premarket high 12.98 at 9:18 AM ET, Support test 9.80 at low PM

Trading Levels:

• Premarket Range: $9.80–$12.98
• Key Support: $9.80 (overnight low), $10.50 (late PM consolidation)
• Entry Zones: → $10.00 / $10.50

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $11.00 | T2 $11.50 | T3 $12.00 | T4 $12.98 | T5 $14.00
• Stop Loss: $9.50 (dynamic, max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 (+72%, RV 24x), Movers Gainers #3
• Volume: 7.77M shares, $86.21M dollar volume (2400% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Gap-up momentum with wide range (5m)
• Catalyst: UNCONFIRMED — manual verification required before entry

---

3️⃣ $IOVA (Iovance Biotherapeutics) | 🧬 Biotechnology

Current Status:

• Price: $3.41 (+17.99%)
• Float: 338M
• Premarket Volume: 3.99M (500% RVOL)
• Key Times: Premarket high 3.51 at 9:18 AM ET, Support test 2.90 at low PM

Trading Levels:

• Premarket Range: $2.90–$3.51
• Key Support: $3.10 (overnight), $3.27 (late PM consolidation)
• Entry Zones: → $3.30 / $3.41

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.51 | T2 $3.75 | T3 $4.00 | T4 $4.25 | T5 $4.50
• Stop Loss: $3.15 (dynamic, max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision Breakout #2 (+13%), #3 (+18%), Movers Gainers #13
• Volume: 3.99M shares, $13.02M dollar volume (500% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Breakout with multiple scanner hits (5m)
• Catalyst: Positive results from first clinical trial for TIL Cell Therapy in Soft Tissue Sarcomas; Q4/FY2025 results — TrendVision NEWS/SEC FORM 8-K

---

4️⃣ $CDIO (Cardio Diagnostics) | 🧬 Diagnostics

Current Status:

• Price: $3.53 (+17.28%)
• Float: 1.7M
• Premarket Volume: 3.41M (1400% RVOL)
• Key Times: Premarket high 3.63 at 9:18 AM ET, Support test 2.89 at low PM

Trading Levels:

• Premarket Range: $2.89–$3.63
• Key Support: $3.01 (overnight), $3.28 (late PM consolidation)
• Entry Zones: → $3.40 / $3.53

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.63 | T2 $3.85 | T3 $4.00 | T4 $4.25 | T5 $4.50
• Stop Loss: $3.20 (dynamic, max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision Breakout #3 (+18%), Momentum #2 (+14%), Movers Gainers #15
• Volume: 3.41M shares, $11.78M dollar volume (1400% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Potential squeeze, known runner with tight float (5m)
• Catalyst: UNCONFIRMED — Potential Squeeze, Known Runner indicator — manual verification required before entry

---

5️⃣ $ELPW (Elong Power) | 🔋 Energy/Power

Current Status:

• Price: $0.458 (+17.36%)
• Float: 1.5M
• Premarket Volume: 34.81M (70900% RVOL)
• Key Times: Premarket high $0.599 at 9:18 AM ET, Support test $0.410 at low PM

Trading Levels:

• Premarket Range: $0.410–$0.599
• Key Support: $0.450 (overnight), $0.525 (late PM consolidation)
• Entry Zones: → $0.500 / $0.530

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $0.560 | T2 $0.589 | T3 $0.620 | T4 $0.660 | T5 $0.700
• Stop Loss: $0.470 (dynamic, max 3–5% risk)
• Trailing Stop: 12% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision Breakout #4 (+49%, RV 832x), Momentum #2 (+33%, RV 709x), #5 (+37%, RV 441x)
• Volume: 34.81M shares, $17.88M dollar volume (70900% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Potential Squeeze, Reg SHO, Known Runner with extreme RVOL (1m/5m)
• Catalyst: UNCONFIRMED — Reg SHO, Potential Squeeze indicator — manual verification required before entry

---

6️⃣ $CLVT (Clarivate) | ☁️ Data Analytics

Current Status:

• Price: $2.05 (+22.02%)
• Float: 430.05M
• Premarket Volume: 875.14K (200% RVOL)
• Key Times: Premarket high $2.21 at 9:18 AM ET, Support test $1.73 at low PM

Trading Levels:

• Premarket Range: $1.73–$2.21
• Key Support: $1.90 (overnight), $2.00 (late PM consolidation)
• Entry Zones: → $2.00 / $2.05

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $2.15 | T2 $2.21 | T3 $2.35 | T4 $2.50 | T5 $2.75
• Stop Loss: $1.90 (dynamic, max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 (+30%, RV 2x), Movers Gainers #6
• Volume: 875.14K shares, $1.81M dollar volume (200% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Gap-up on earnings with consolidation (5m)
• Catalyst: Clarivate Reports Fourth Quarter and Full Year 2025 Results — TrendVision NEWS/SEC FORM 10-K, FORM 8-K

---

7️⃣ $EDSA (Edesa Biotech) | 🧬 Biotechnology

Current Status:

• Price: $1.03 (+15%)
• Float: 7.3M
• Premarket Volume: Data unavailable — check Finviz/Yahoo
• Key Times: Huge S breakout flagged 8:15 AM ET

Trading Levels:

• Premarket Range: $0.90–$1.10 (estimated from scanner)
• Key Support: $0.95 (overnight), $1.00 (late PM consolidation)
• Entry Zones: → $1.00 / $1.05

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $1.15 | T2 $1.25 | T3 $1.35 | T4 $1.50 | T5 $1.75
• Stop Loss: $0.93 (dynamic, max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision HUGE_S #1 (+15%, RV 6x, MC 7.5M)
• Volume: Data unavailable — check Finviz/Yahoo
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Huge size breakout (1m)
• Catalyst: Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study — TrendVision NEWS

---

8️⃣ $TLIH (Ten-League International Holdings) | 📚 Holdings/Diversified

Current Status:

• Price: $0.483 (+51.79%)
• Float: 5.0M
• Premarket Volume: 57.16M (4300% RVOL)
• Key Times: Premarket high $0.555 at 9:18 AM ET, Support test $0.316 at low PM

Trading Levels:

• Premarket Range: $0.316–$0.555
• Key Support: $0.420 (overnight), $0.470 (late PM consolidation)
• Entry Zones: → $0.500 / $0.520

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $0.555 | T2 $0.580 | T3 $0.620 | T4 $0.660 | T5 $0.700
• Stop Loss: $0.460 (dynamic, max 3–5% risk)
• Trailing Stop: 12% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision Breakout #2 (+30%, RV 11x), Momentum #3 (+50%, RV 43x), Movers Gainers #1
• Volume: 57.16M shares, $28.11M dollar volume (4300% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Momentum breakout with extreme volume and tight float (1m/5m)
• Catalyst: Ten-League International Holdings Limited Announces Fiscal Year 2025 Guidance — TrendVision NEWS/SEC FORM 6-K

---

9️⃣ $RIME (Algorhythm Holdings / SemiCab) | 🚚 Technology/Logistics

Current Status:

• Price: $2.10 (+13.86%)
• Float: 2.1M
• Premarket Volume: 913.26K (1200% RVOL)
• Key Times: Premarket high $2.15 at 9:18 AM ET, Support test $1.71 at low PM

Trading Levels:

• Premarket Range: $1.71–$2.15
• Key Support: $1.85 (overnight), $1.98 (late PM consolidation)
• Entry Zones: → $2.00 / $2.10

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $2.15 | T2 $2.30 | T3 $2.50 | T4 $2.75 | T5 $3.00
• Stop Loss: $1.90 (dynamic, max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 (+6%, RV 4x), #2 (+9%, RV 12x), Potential Squeeze/Reg SHO/Known Runner
• Volume: 913.26K shares, $1.85M dollar volume (1200% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Potential squeeze with Reg SHO, known runner (5m)
• Catalyst: SemiCab Awarded Pilot with Coca-Cola India — TrendVision NEWS

---

🔟 $ALUR (Allurion Technologies) | 🏥 Medical Devices

Current Status:

• Price: $1.55 (+14%)
• Float: 11M
• Premarket Volume: 534K (211% RVOL)
• Key Times: Medium whale alert at $1.53 (126.65K shares, $193.77K value)

Trading Levels:

• Premarket Range: $1.35–$1.60 (estimated from scanner)
• Key Support: $1.40 (overnight), $1.50 (late PM consolidation)
• Entry Zones: → $1.50 / $1.55

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $1.65 | T2 $1.75 | T3 $1.90 | T4 $2.00 | T5 $2.25
• Stop Loss: $1.42 (dynamic, max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 (+14%, RV 211x, MC 14M)
• Volume: 534K shares, estimated $828K dollar volume (211% RVOL)
• Indicators: Unavailable — confirm on chart before entry
• Pattern: Whale accumulation with analyst upgrade (1m)
• Catalyst: Allurion Announces Exercise of Warrants for $3.0M in Gross Proceeds; Chardan Capital Upgrades to Buy, Raises Price Target to $3 — TrendVision NEWS

 

1️⃣ $VIR (Vir Biotechnology Inc.) | 🧬 Biotech/Oncology

Current Status:

• Price: $11.80 (+58.81%)
• Float: 85.53M
• After-Hours Volume: 9.32M (2,400%+ RVOL)
• Key Times: After-hours high 4:44 PM ET, Support test 4:02 PM ET

Trading Levels:

• After-Hours Range: $7.43–$12.00
• Key Support: $9.57 (mid-AH consolidation), $10.65 (late AH breakout)
• Entry Zones: → $11.00 / $11.60

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $12.00 | T2 $12.50 | T3 $13.25 | T4 $14.00 | T5 $15.00
• Stop Loss: $10.45 (dynamic, max 5% risk)
• Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #2 Momentum +28% RV 14x, #4 Breakout +54% RV 31x, #5 Breakout +59% RV 37x, #3 Momentum +41% RV 24x
• Volume: 9.32M shares, $109.93M dollar volume (2,400%+ RVOL)
• Indicators: RSI overbought, MACD strong bullish crossover, OBV surging, above VWAP, higher lows from $7.43, above 9 EMA/20 MA
• Pattern: Parabolic breakout with stair-step higher lows through AH (5m)
• Catalyst: Vir Biotechnology Reports Positive Updated Phase 1 Results for PRO-XTEN Dual-masked T-Cell Engager VIR-5500 in Metastatic Prostate Cancer; Astellas and Vir Announce Global Strategic Collaboration — Vir Biotechnology press release, 02/24/2026

---

2️⃣ $MYGN (Myriad Genetics Inc.) | 🧬 Biotech/Diagnostics

Current Status:

• Price: $5.43 (+23.97%)
• Float: 89M
• After-Hours Volume: 1.16M (1,300%+ RVOL)
• Key Times: After-hours high 3:15 PM ET, Support test 3:00 PM ET

Trading Levels:

• After-Hours Range: $4.38–$5.43
• Key Support: $5.15 (late AH consolidation), $5.00 (psychological)
• Entry Zones: → $5.15 / $5.41

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $5.75 | T2 $6.00 | T3 $6.50 | T4 $7.00 | T5 $7.50
• Stop Loss: $4.90 (dynamic, max 5% risk)
• Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +20% RV 3x, #2 Breakout +26% RV 13x
• Volume: 1.16M shares, $6.30M dollar volume (1,300%+ RVOL)
• Indicators: RSI elevated, MACD bullish crossover, OBV rising, above VWAP, higher lows from $4.38, above 9 EMA/20 MA
• Pattern: Earnings gap-up with consolidation near highs (5m)
• Catalyst: Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution — Myriad Genetics press release, 02/24/2026

---

3️⃣ $SGHC (Super Group Ltd.) | 🎰 Consumer/Online Gaming

Current Status:

• Price: $11.32 (+16.48%)
• Float: 153M
• After-Hours Volume: 1.25M (900%+ RVOL)
• Key Times: After-hours high 3:15 PM ET, Support test 3:00 PM ET

Trading Levels:

• After-Hours Range: $9.72–$11.32
• Key Support: $10.50 (mid-AH level), $11.03 (late AH breakout)
• Entry Zones: → $11.00 / $11.30

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $11.75 | T2 $12.00 | T3 $12.50 | T4 $13.00 | T5 $14.00
• Stop Loss: $10.45 (dynamic, max 5% risk)
• Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +6% RV 4x, #2 Breakout +15% RV 9x
• Volume: 1.25M shares, $14.15M dollar volume (900%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, higher lows from $9.72, above 9 EMA/20 MA
• Pattern: Earnings breakout with consolidation near highs (5m)
• Catalyst: Super Group Reports Financial Results for Fourth Quarter and Full Year 2025 — Super Group press release/Form 6-K, 02/24/2026

---

4️⃣ $MGRX (Mangoceuticals Inc.) | 🧬 Biotech/Avian Health

Current Status:

• Price: $0.545 (+3.00%)
• Float: 13M
• After-Hours Volume: 6.20M (5,900%+ RVOL)
• Key Times: After-hours high 3:00 PM ET, Support test 3:08 PM ET

Trading Levels:

• After-Hours Range: $0.520–$0.545
• Key Support: $0.520 (AH low), $0.530 (consolidation)
• Entry Zones: → $0.530 / $0.545

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $0.580 | T2 $0.620 | T3 $0.660 | T4 $0.700 | T5 $0.750
• Stop Loss: $0.500 (dynamic, max 5% risk)
• Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #2 +3% RV 59x
• Volume: 6.20M shares, $3.38M dollar volume (5,900%+ RVOL)
• Indicators: RSI neutral, MACD resetting bullish, OBV elevated, watching VWAP reclaim, above 9 EMA
• Pattern: Consolidation near highs with massive RVOL (1m/5m)
• Catalyst: Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study — Mangoceuticals press release, 02/24/2026

---

5️⃣ $SILO (Silo Pharma Inc.) | 🧬 Biotech/Psychedelics

Current Status:

• Price: $0.390 (+38.69%)
• Float: 13M
• After-Hours Volume: 14.55M (2,200%+ RVOL)
• Key Times: After-hours high 3:27 PM ET, Support test 3:00 PM ET

Trading Levels:

• After-Hours Range: $0.280–$0.424
• Key Support: $0.359 (mid-AH consolidation), $0.375 (late AH level)
• Entry Zones: → $0.375 / $0.390

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $0.424 | T2 $0.450 | T3 $0.500 | T4 $0.550 | T5 $0.600
• Stop Loss: $0.350 (dynamic, max 5% risk)
• Trailing Stop: 12% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #3 Momentum +31% RV 22x, #4 Momentum +48% RV 36x, #2 Momentum +25% RV 16x, 0 Borrow CTB 6.52%
• Volume: 14.55M shares, $5.67M dollar volume (2,200%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV surging, above VWAP, higher lows from $0.280, above 9 EMA/20 MA
• Pattern: Momentum breakout with stair-step higher through AH (5m)
• Catalyst: Silo Pharma Announces Share Buyback Program — Silo Pharma press release, 02/24/2026

---

6️⃣ $GIPR (Generation Income Properties Inc.) | 🏗️ Real Estate/REIT

Current Status:

• Price: $0.670 (+24.07%)
• Float: 4.6M
• After-Hours Volume: 5.95M (2,400%+ RVOL)
• Key Times: After-hours high 3:48 PM ET, Support test 3:00 PM ET

Trading Levels:

• After-Hours Range: $0.540–$0.819
• Key Support: $0.590 (early AH level), $0.680 (mid-AH breakout)
• Entry Zones: → $0.670 / $0.700

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $0.766 | T2 $0.819 | T3 $0.900 | T4 $1.00 | T5 $1.15
• Stop Loss: $0.620 (dynamic, max 5% risk)
• Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +3% RV 0.54x, #2 Breakout +18% RV 3x, #3 REV +23% RV 7x, #4 Breakout +43% RV 24x
• Volume: 5.95M shares, $3.99M dollar volume (2,400%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV surging, above VWAP, higher lows from $0.540, above 9 EMA/20 MA
• Pattern: Multi-hit breakout with wide range and consolidation near highs (5m)
• Catalyst: SEC Form 8-K/A and Form 8-K filings — SEC/EDGAR, 02/24/2026

---

7️⃣ $GNPX (Genprex Inc.) | 🧬 Biotech/Gene Therapy

Current Status:

• Price: $2.55 (+43.00%)
• Float: 2.2M
• After-Hours Volume: 1.70M (1,200%+ RVOL)
• Key Times: After-hours high 6:13 PM ET, Support test 5:14 PM ET

Trading Levels:

• After-Hours Range: $1.78–$2.55
• Key Support: $2.20 (mid-AH consolidation), $2.40 (late AH level)
• Entry Zones: → $2.40 / $2.55

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $2.75 | T2 $3.00 | T3 $3.25 | T4 $3.50 | T5 $4.00
• Stop Loss: $2.25 (dynamic, max 5% risk)
• Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #4 Breakout +43% RV 12x, Known Runner
• Volume: 1.70M shares, $4.34M dollar volume (1,200%+ RVOL)
• Indicators: RSI overbought, MACD strong bullish, OBV surging, above VWAP, higher lows from $1.78, above 9 EMA/20 MA
• Pattern: Low float breakout with Known Runner tag and consolidation near highs (5m)
• Catalyst: Genprex Strengthens In... (strategic update) — Genprex press release/Form 8-K, 02/24/2026

---

8️⃣ $KYNB (Kyntra Bio Inc.) | 🧬 Biotech/Oncology

Current Status:

• Price: $9.23 (+11.00%)
• Float: 3.8M
• After-Hours Volume: 1.00M (200%+ RVOL)
• Key Times: After-hours high 4:10 PM ET, Support test 4:00 PM ET

Trading Levels:

• After-Hours Range: $8.31–$9.23
• Key Support: $8.50 (early AH level), $9.00 (psychological)
• Entry Zones: → $9.00 / $9.23

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $9.75 | T2 $10.00 | T3 $10.50 | T4 $11.00 | T5 $12.00
• Stop Loss: $8.55 (dynamic, max 5% risk)
• Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +11% RV 2x
• Volume: 1.00M shares, $9.23M dollar volume (200%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, above 9 EMA/20 MA
• Pattern: Gap-up with consolidation near highs (5m)
• Catalyst: Kyntra Bio Announces Positive Data from Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 — Kyntra Bio press release, 02/24/2026

---

9️⃣ $TARA (Protara Therapeutics Inc.) | 🧬 Biotech/Oncology

Current Status:

• Price: $7.50 (+10.00%)
• Float: 47M
• After-Hours Volume: 5.00M (200%+ RVOL)
• Key Times: After-hours high 4:02 PM ET, Support test 4:00 PM ET

Trading Levels:

• After-Hours Range: $6.82–$7.50
• Key Support: $7.00 (psychological), $7.25 (mid-AH level)
• Entry Zones: → $7.25 / $7.50

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $7.85 | T2 $8.00 | T3 $8.50 | T4 $9.00 | T5 $10.00
• Stop Loss: $6.90 (dynamic, max 5% risk)
• Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +10% RV 2x
• Volume: 5.00M shares, $37.50M dollar volume (200%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, above 9 EMA/20 MA
• Pattern: Gap-up with consolidation near highs (5m)
• Catalyst: TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer — Protara Therapeutics press release, 02/24/2026

---

🔟 $BOXL (Boxlight Corporation) | 🤖 Technology/EdTech

Current Status:

• Price: $1.64 (+11.56%)
• Float: 930K
• After-Hours Volume: 1.97M (800%+ RVOL)
• Key Times: After-hours high 3:38 PM ET, Support test 3:27 PM ET

Trading Levels:

• After-Hours Range: $1.47–$1.70
• Key Support: $1.55 (early AH level), $1.60 (late AH consolidation)
• Entry Zones: → $1.60 / $1.64

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $1.75 | T2 $1.85 | T3 $2.00 | T4 $2.20 | T5 $2.50
• Stop Loss: $1.50 (dynamic, max 5% risk)
• Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

• Scanner Hits: TrendVision #1 +16% RV 4x, #2 Momentum +16% RV 8x, R/S 1:6 2 months ago, Potential Squeeze
• Volume: 1.97M shares, $3.23M dollar volume (800%+ RVOL)
• Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, higher lows from $1.47, above 9 EMA/20 MA
• Pattern: Ultra-low float potential squeeze with R/S history and consolidation near highs (5m)
• Catalyst: SEC Form 8-K filing; Potential Squeeze with 930K ultra-low float and R/S 1:6 two months ago — SEC/EDGAR/TrendVision scanner, 02/24/2026